Trump unveils healthcare plan featuring direct payments over insurance subsidies
Trump announces plan as millions face rising insurance costs White House calls on Congress to pass it into…
Exclusive: US FDA delays two drug reviews in new voucher program after safety, efficacy concerns
Reviews of Sanofi’s diabetes drug Tzield and Disc Medicine’s blood-disorder medicine bitopertin stalled Tzield pushed back after adverse…
Drugmakers brace for Europe pricing fight after Trump’s US price-cut deals
Pricing deals with Trump added pressure to hike Europe prices Trump says other wealthy countries should pay more…
Exclusive: Drugmakers raise US prices on 350 medicines despite pressure from Trump
Number of hikes rises from same time a year ago Median list price increase is 4%, in line…
Kenvue urges US FDA to reject request for Tylenol’s autism warning
Oct 20 (Reuters) – Kenvue (KVUE.N), opens new tab has urged U.S. regulators to reject a request seeking…